nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Temozolomide—malignant glioma	0.53	1	CbGbCtD
Tadalafil—Transient ischaemic attack—Temozolomide—malignant glioma	0.0131	0.0323	CcSEcCtD
Tadalafil—Scotoma—Carmustine—malignant glioma	0.00899	0.0222	CcSEcCtD
Tadalafil—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00892	0.022	CcSEcCtD
Tadalafil—Menorrhagia—Temozolomide—malignant glioma	0.00892	0.022	CcSEcCtD
Tadalafil—Scotoma—Temozolomide—malignant glioma	0.00869	0.0215	CcSEcCtD
Tadalafil—PDE5A—endothelium—malignant glioma	0.00866	0.24	CbGeAlD
Tadalafil—PDE5A—blood vessel—malignant glioma	0.00798	0.221	CbGeAlD
Tadalafil—Hearing impaired—Temozolomide—malignant glioma	0.00693	0.0171	CcSEcCtD
Tadalafil—Neck pain—Carmustine—malignant glioma	0.00691	0.0171	CcSEcCtD
Tadalafil—Swelling—Carmustine—malignant glioma	0.00562	0.0139	CcSEcCtD
Tadalafil—Eye pain—Carmustine—malignant glioma	0.00549	0.0136	CcSEcCtD
Tadalafil—Gastroenteritis—Temozolomide—malignant glioma	0.0054	0.0134	CcSEcCtD
Tadalafil—Deafness—Temozolomide—malignant glioma	0.00535	0.0132	CcSEcCtD
Tadalafil—Eye pain—Temozolomide—malignant glioma	0.00531	0.0131	CcSEcCtD
Tadalafil—Amnesia—Carmustine—malignant glioma	0.00528	0.013	CcSEcCtD
Tadalafil—Nasal congestion—Temozolomide—malignant glioma	0.00526	0.013	CcSEcCtD
Tadalafil—Hot flush—Temozolomide—malignant glioma	0.00512	0.0127	CcSEcCtD
Tadalafil—Amnesia—Temozolomide—malignant glioma	0.0051	0.0126	CcSEcCtD
Tadalafil—Menopausal symptoms—Temozolomide—malignant glioma	0.00508	0.0125	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00508	0.0125	CcSEcCtD
Tadalafil—Face oedema—Carmustine—malignant glioma	0.00479	0.0118	CcSEcCtD
Tadalafil—Face oedema—Temozolomide—malignant glioma	0.00462	0.0114	CcSEcCtD
Tadalafil—PDE11A—brain—malignant glioma	0.00459	0.127	CbGeAlD
Tadalafil—Liver function test abnormal—Carmustine—malignant glioma	0.00458	0.0113	CcSEcCtD
Tadalafil—Breast disorder—Temozolomide—malignant glioma	0.00433	0.0107	CcSEcCtD
Tadalafil—Dysphagia—Carmustine—malignant glioma	0.00428	0.0106	CcSEcCtD
Tadalafil—PDE5A—retina—malignant glioma	0.00421	0.117	CbGeAlD
Tadalafil—Dysphagia—Temozolomide—malignant glioma	0.00414	0.0102	CcSEcCtD
Tadalafil—Bronchitis—Temozolomide—malignant glioma	0.00398	0.00984	CcSEcCtD
Tadalafil—PDE5A—telencephalon—malignant glioma	0.00387	0.107	CbGeAlD
Tadalafil—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00385	0.00951	CcSEcCtD
Tadalafil—Renal failure—Carmustine—malignant glioma	0.00375	0.00928	CcSEcCtD
Tadalafil—Urinary tract infection—Carmustine—malignant glioma	0.00371	0.00917	CcSEcCtD
Tadalafil—Infestation NOS—Temozolomide—malignant glioma	0.00369	0.00912	CcSEcCtD
Tadalafil—Infestation—Temozolomide—malignant glioma	0.00369	0.00912	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00366	0.00904	CcSEcCtD
Tadalafil—Urinary tract infection—Temozolomide—malignant glioma	0.00359	0.00886	CcSEcCtD
Tadalafil—Haemoglobin—Carmustine—malignant glioma	0.00345	0.00851	CcSEcCtD
Tadalafil—Haemorrhage—Carmustine—malignant glioma	0.00343	0.00847	CcSEcCtD
Tadalafil—Hypoaesthesia—Carmustine—malignant glioma	0.00341	0.00843	CcSEcCtD
Tadalafil—Oedema peripheral—Carmustine—malignant glioma	0.00338	0.00835	CcSEcCtD
Tadalafil—Connective tissue disorder—Carmustine—malignant glioma	0.00337	0.00832	CcSEcCtD
Tadalafil—Haemoglobin—Temozolomide—malignant glioma	0.00333	0.00823	CcSEcCtD
Tadalafil—Haemorrhage—Temozolomide—malignant glioma	0.00331	0.00819	CcSEcCtD
Tadalafil—Hypoaesthesia—Temozolomide—malignant glioma	0.0033	0.00815	CcSEcCtD
Tadalafil—Pharyngitis—Temozolomide—malignant glioma	0.00329	0.00813	CcSEcCtD
Tadalafil—Urinary tract disorder—Temozolomide—malignant glioma	0.00327	0.00808	CcSEcCtD
Tadalafil—Oedema peripheral—Temozolomide—malignant glioma	0.00326	0.00806	CcSEcCtD
Tadalafil—Connective tissue disorder—Temozolomide—malignant glioma	0.00326	0.00804	CcSEcCtD
Tadalafil—Urethral disorder—Temozolomide—malignant glioma	0.00325	0.00802	CcSEcCtD
Tadalafil—Eye disorder—Carmustine—malignant glioma	0.0032	0.00792	CcSEcCtD
Tadalafil—Flushing—Carmustine—malignant glioma	0.00318	0.00786	CcSEcCtD
Tadalafil—Erythema multiforme—Temozolomide—malignant glioma	0.00313	0.00774	CcSEcCtD
Tadalafil—Eye disorder—Temozolomide—malignant glioma	0.0031	0.00765	CcSEcCtD
Tadalafil—Tinnitus—Temozolomide—malignant glioma	0.00309	0.00763	CcSEcCtD
Tadalafil—Flushing—Temozolomide—malignant glioma	0.00308	0.0076	CcSEcCtD
Tadalafil—Cardiac disorder—Temozolomide—malignant glioma	0.00308	0.0076	CcSEcCtD
Tadalafil—Angiopathy—Temozolomide—malignant glioma	0.00301	0.00743	CcSEcCtD
Tadalafil—Mental disorder—Carmustine—malignant glioma	0.003	0.00742	CcSEcCtD
Tadalafil—Immune system disorder—Temozolomide—malignant glioma	0.00299	0.00739	CcSEcCtD
Tadalafil—Mediastinal disorder—Temozolomide—malignant glioma	0.00299	0.00738	CcSEcCtD
Tadalafil—Mental disorder—Temozolomide—malignant glioma	0.0029	0.00717	CcSEcCtD
Tadalafil—Back pain—Carmustine—malignant glioma	0.00289	0.00713	CcSEcCtD
Tadalafil—Vision blurred—Carmustine—malignant glioma	0.00281	0.00695	CcSEcCtD
Tadalafil—Back pain—Temozolomide—malignant glioma	0.00279	0.00689	CcSEcCtD
Tadalafil—Vision blurred—Temozolomide—malignant glioma	0.00272	0.00672	CcSEcCtD
Tadalafil—Angioedema—Temozolomide—malignant glioma	0.00264	0.00651	CcSEcCtD
Tadalafil—Vertigo—Temozolomide—malignant glioma	0.00259	0.0064	CcSEcCtD
Tadalafil—Convulsion—Carmustine—malignant glioma	0.00259	0.00639	CcSEcCtD
Tadalafil—Hypertension—Carmustine—malignant glioma	0.00258	0.00637	CcSEcCtD
Tadalafil—Palpitations—Temozolomide—malignant glioma	0.00255	0.0063	CcSEcCtD
Tadalafil—Myalgia—Carmustine—malignant glioma	0.00254	0.00628	CcSEcCtD
Tadalafil—Chest pain—Carmustine—malignant glioma	0.00254	0.00628	CcSEcCtD
Tadalafil—Cough—Temozolomide—malignant glioma	0.00252	0.00622	CcSEcCtD
Tadalafil—Convulsion—Temozolomide—malignant glioma	0.0025	0.00617	CcSEcCtD
Tadalafil—Hypertension—Temozolomide—malignant glioma	0.00249	0.00615	CcSEcCtD
Tadalafil—Arthralgia—Temozolomide—malignant glioma	0.00246	0.00607	CcSEcCtD
Tadalafil—Myalgia—Temozolomide—malignant glioma	0.00246	0.00607	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00244	0.00603	CcSEcCtD
Tadalafil—Oedema—Carmustine—malignant glioma	0.00244	0.00602	CcSEcCtD
Tadalafil—Discomfort—Temozolomide—malignant glioma	0.00243	0.00599	CcSEcCtD
Tadalafil—Infection—Carmustine—malignant glioma	0.00242	0.00598	CcSEcCtD
Tadalafil—Dry mouth—Temozolomide—malignant glioma	0.0024	0.00593	CcSEcCtD
Tadalafil—Tachycardia—Carmustine—malignant glioma	0.00238	0.00587	CcSEcCtD
Tadalafil—Oedema—Temozolomide—malignant glioma	0.00235	0.00582	CcSEcCtD
Tadalafil—Infection—Temozolomide—malignant glioma	0.00234	0.00578	CcSEcCtD
Tadalafil—Nervous system disorder—Temozolomide—malignant glioma	0.00231	0.0057	CcSEcCtD
Tadalafil—Skin disorder—Temozolomide—malignant glioma	0.00229	0.00565	CcSEcCtD
Tadalafil—Hypotension—Carmustine—malignant glioma	0.00228	0.00562	CcSEcCtD
Tadalafil—Hyperhidrosis—Temozolomide—malignant glioma	0.00228	0.00562	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00222	0.00548	CcSEcCtD
Tadalafil—Insomnia—Carmustine—malignant glioma	0.0022	0.00544	CcSEcCtD
Tadalafil—PDE5A—central nervous system—malignant glioma	0.0022	0.061	CbGeAlD
Tadalafil—Paraesthesia—Carmustine—malignant glioma	0.00219	0.0054	CcSEcCtD
Tadalafil—Dyspnoea—Carmustine—malignant glioma	0.00217	0.00537	CcSEcCtD
Tadalafil—Somnolence—Carmustine—malignant glioma	0.00217	0.00535	CcSEcCtD
Tadalafil—PDE5A—cerebellum—malignant glioma	0.00215	0.0596	CbGeAlD
Tadalafil—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00214	0.0053	CcSEcCtD
Tadalafil—Insomnia—Temozolomide—malignant glioma	0.00213	0.00526	CcSEcCtD
Tadalafil—Paraesthesia—Temozolomide—malignant glioma	0.00211	0.00522	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Carmustine—malignant glioma	0.0021	0.0052	CcSEcCtD
Tadalafil—Dyspnoea—Temozolomide—malignant glioma	0.0021	0.00519	CcSEcCtD
Tadalafil—Somnolence—Temozolomide—malignant glioma	0.00209	0.00517	CcSEcCtD
Tadalafil—Constipation—Carmustine—malignant glioma	0.00208	0.00515	CcSEcCtD
Tadalafil—Pain—Carmustine—malignant glioma	0.00208	0.00515	CcSEcCtD
Tadalafil—Dyspepsia—Temozolomide—malignant glioma	0.00207	0.00512	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00203	0.00502	CcSEcCtD
Tadalafil—Fatigue—Temozolomide—malignant glioma	0.00203	0.00501	CcSEcCtD
Tadalafil—Pain—Temozolomide—malignant glioma	0.00201	0.00497	CcSEcCtD
Tadalafil—Constipation—Temozolomide—malignant glioma	0.00201	0.00497	CcSEcCtD
Tadalafil—Gastrointestinal pain—Carmustine—malignant glioma	0.00199	0.00492	CcSEcCtD
Tadalafil—Abdominal pain—Carmustine—malignant glioma	0.00193	0.00476	CcSEcCtD
Tadalafil—Gastrointestinal pain—Temozolomide—malignant glioma	0.00193	0.00476	CcSEcCtD
Tadalafil—Urticaria—Temozolomide—malignant glioma	0.00187	0.00462	CcSEcCtD
Tadalafil—Abdominal pain—Temozolomide—malignant glioma	0.00186	0.0046	CcSEcCtD
Tadalafil—Hypersensitivity—Carmustine—malignant glioma	0.00179	0.00443	CcSEcCtD
Tadalafil—PDE5A—brain—malignant glioma	0.00175	0.0484	CbGeAlD
Tadalafil—Asthenia—Carmustine—malignant glioma	0.00175	0.00432	CcSEcCtD
Tadalafil—Hypersensitivity—Temozolomide—malignant glioma	0.00173	0.00429	CcSEcCtD
Tadalafil—Asthenia—Temozolomide—malignant glioma	0.00169	0.00417	CcSEcCtD
Tadalafil—Diarrhoea—Carmustine—malignant glioma	0.00167	0.00412	CcSEcCtD
Tadalafil—Pruritus—Temozolomide—malignant glioma	0.00167	0.00411	CcSEcCtD
Tadalafil—Dizziness—Carmustine—malignant glioma	0.00161	0.00398	CcSEcCtD
Tadalafil—Diarrhoea—Temozolomide—malignant glioma	0.00161	0.00398	CcSEcCtD
Tadalafil—Dizziness—Temozolomide—malignant glioma	0.00156	0.00385	CcSEcCtD
Tadalafil—Vomiting—Carmustine—malignant glioma	0.00155	0.00383	CcSEcCtD
Tadalafil—Rash—Carmustine—malignant glioma	0.00154	0.00379	CcSEcCtD
Tadalafil—Dermatitis—Carmustine—malignant glioma	0.00153	0.00379	CcSEcCtD
Tadalafil—Headache—Carmustine—malignant glioma	0.00153	0.00377	CcSEcCtD
Tadalafil—Vomiting—Temozolomide—malignant glioma	0.0015	0.0037	CcSEcCtD
Tadalafil—Rash—Temozolomide—malignant glioma	0.00148	0.00367	CcSEcCtD
Tadalafil—Dermatitis—Temozolomide—malignant glioma	0.00148	0.00366	CcSEcCtD
Tadalafil—Headache—Temozolomide—malignant glioma	0.00147	0.00364	CcSEcCtD
Tadalafil—Nausea—Carmustine—malignant glioma	0.00145	0.00357	CcSEcCtD
Tadalafil—Nausea—Temozolomide—malignant glioma	0.0014	0.00345	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—DOCK6—malignant glioma	0.00105	0.0356	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—DOCK6—malignant glioma	0.000932	0.0317	CbGpPWpGaD
Tadalafil—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000927	0.0316	CbGpPWpGaD
Tadalafil—PDE11A—Platelet homeostasis—PTPN11—malignant glioma	0.000698	0.0238	CbGpPWpGaD
Tadalafil—CYP3A4—central nervous system—malignant glioma	0.000686	0.019	CbGeAlD
Tadalafil—PDE11A—Hemostasis—ATP1B2—malignant glioma	0.000633	0.0216	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000627	0.0213	CbGpPWpGaD
Tadalafil—PDE5A—Platelet homeostasis—PTPN11—malignant glioma	0.000622	0.0212	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ATP1B2—malignant glioma	0.000565	0.0192	CbGpPWpGaD
Tadalafil—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000532	0.0181	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—ANGPT2—malignant glioma	0.000467	0.0159	CbGpPWpGaD
Tadalafil—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000461	0.0157	CbGpPWpGaD
Tadalafil—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000432	0.0147	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ANGPT2—malignant glioma	0.000416	0.0142	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—HIST1H3B—malignant glioma	0.000404	0.0138	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MYB—malignant glioma	0.000401	0.0136	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LATS2—malignant glioma	0.000398	0.0135	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000384	0.0131	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000365	0.0124	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—HIST1H3B—malignant glioma	0.00036	0.0123	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MYB—malignant glioma	0.000357	0.0122	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000348	0.0119	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—H3F3A—malignant glioma	0.000312	0.0106	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—LATS1—malignant glioma	0.000301	0.0103	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—H3F3A—malignant glioma	0.000278	0.00948	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CCR4—malignant glioma	0.000263	0.00896	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—KNG1—malignant glioma	0.000257	0.00877	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IFNA2—malignant glioma	0.000252	0.00859	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—SOD1—malignant glioma	0.000239	0.00814	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CCR4—malignant glioma	0.000239	0.00814	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000237	0.00807	CbGpPWpGaD
Tadalafil—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000235	0.008	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KNG1—malignant glioma	0.000229	0.00781	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IFNA2—malignant glioma	0.000225	0.00766	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000221	0.00753	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PTK2—malignant glioma	0.00022	0.00748	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000218	0.00743	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—SOD1—malignant glioma	0.000213	0.00726	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MDK—malignant glioma	0.000204	0.00693	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PTK2—malignant glioma	0.000196	0.00666	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCR3—malignant glioma	0.000195	0.00666	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DTX1—malignant glioma	0.000194	0.00661	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000192	0.00653	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000189	0.00644	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PDGFB—malignant glioma	0.000184	0.00628	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000179	0.0061	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—BDKRB2—malignant glioma	0.000179	0.00609	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCR3—malignant glioma	0.000178	0.00605	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—CAV1—malignant glioma	0.000175	0.00595	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—F2—malignant glioma	0.000166	0.00567	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—FN1—malignant glioma	0.000166	0.00567	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PDGFB—malignant glioma	0.000164	0.0056	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—KNG1—malignant glioma	0.000163	0.00554	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—BDKRB2—malignant glioma	0.000162	0.00553	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CG—malignant glioma	0.000159	0.00542	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—EGF—malignant glioma	0.000157	0.00536	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PTPN11—malignant glioma	0.000156	0.00533	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—CAV1—malignant glioma	0.000156	0.00531	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000155	0.00529	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SUFU—malignant glioma	0.000154	0.00525	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HEY2—malignant glioma	0.000152	0.00519	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GFAP—malignant glioma	0.000149	0.00507	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—F2—malignant glioma	0.000148	0.00505	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—FN1—malignant glioma	0.000148	0.00505	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KNG1—malignant glioma	0.000148	0.00503	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT2—malignant glioma	0.000146	0.00496	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SPHK1—malignant glioma	0.000144	0.00491	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CG—malignant glioma	0.000142	0.00483	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCR4—malignant glioma	0.000141	0.00481	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HEY1—malignant glioma	0.000141	0.00481	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—EGF—malignant glioma	0.00014	0.00478	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CD—malignant glioma	0.00014	0.00477	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PTPN11—malignant glioma	0.000139	0.00475	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIST1H3B—malignant glioma	0.000137	0.00467	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MMP3—malignant glioma	0.000131	0.00446	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT2—malignant glioma	0.00013	0.00442	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000129	0.0044	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JAG2—malignant glioma	0.000125	0.00426	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—RAF1—malignant glioma	0.000125	0.00426	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CD—malignant glioma	0.000125	0.00425	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CB—malignant glioma	0.000122	0.00416	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000118	0.00401	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—IL2—malignant glioma	0.000112	0.00382	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000111	0.0038	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—RAF1—malignant glioma	0.000111	0.00379	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CB—malignant glioma	0.000109	0.0037	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—H3F3A—malignant glioma	0.000106	0.00361	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—F2—malignant glioma	0.000105	0.00358	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCR3—malignant glioma	0.000105	0.00357	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—YWHAE—malignant glioma	0.000102	0.00347	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTRK2—malignant glioma	0.000102	0.00347	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FLT1—malignant glioma	0.000102	0.00346	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DUSP6—malignant glioma	0.000101	0.00344	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CG—malignant glioma	0.000101	0.00343	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—IL2—malignant glioma	9.99e-05	0.0034	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JAG1—malignant glioma	9.98e-05	0.0034	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH3—malignant glioma	9.94e-05	0.00339	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FBXW7—malignant glioma	9.78e-05	0.00333	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BDKRB2—malignant glioma	9.59e-05	0.00327	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—F2—malignant glioma	9.55e-05	0.00325	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—VEGFA—malignant glioma	9.52e-05	0.00324	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	9.52e-05	0.00324	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	9.39e-05	0.0032	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT2—malignant glioma	9.21e-05	0.00314	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CG—malignant glioma	9.14e-05	0.00311	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PTPN11—malignant glioma	8.98e-05	0.00306	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH2—malignant glioma	8.92e-05	0.00304	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CD—malignant glioma	8.84e-05	0.00301	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KNG1—malignant glioma	8.73e-05	0.00297	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—VEGFA—malignant glioma	8.49e-05	0.00289	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT2—malignant glioma	8.36e-05	0.00285	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NTRK1—malignant glioma	8.32e-05	0.00283	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	8.25e-05	0.00281	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	8.14e-05	0.00277	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—KRAS—malignant glioma	8.09e-05	0.00276	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CD—malignant glioma	8.03e-05	0.00274	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP3—malignant glioma	7.73e-05	0.00263	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CB—malignant glioma	7.71e-05	0.00263	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN2B—malignant glioma	7.66e-05	0.00261	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTK2—malignant glioma	7.44e-05	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—malignant glioma	7.44e-05	0.00253	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—malignant glioma	7.41e-05	0.00252	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HES1—malignant glioma	7.31e-05	0.00249	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NCOR1—malignant glioma	7.27e-05	0.00248	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—KRAS—malignant glioma	7.21e-05	0.00246	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—malignant glioma	7.19e-05	0.00245	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RAF1—malignant glioma	7.17e-05	0.00244	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	7.14e-05	0.00243	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2—malignant glioma	7.08e-05	0.00241	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CB—malignant glioma	7e-05	0.00238	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDGFRA—malignant glioma	6.96e-05	0.00237	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SPP1—malignant glioma	6.76e-05	0.0023	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—malignant glioma	6.73e-05	0.00229	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.67e-05	0.00227	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—malignant glioma	6.63e-05	0.00226	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL2—malignant glioma	6.43e-05	0.00219	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—malignant glioma	6.41e-05	0.00218	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TERT—malignant glioma	6.41e-05	0.00218	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—PTGS1—malignant glioma	6.25e-05	0.00213	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PDGFB—malignant glioma	6.25e-05	0.00213	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGFR1—malignant glioma	6.22e-05	0.00212	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—malignant glioma	6.13e-05	0.00209	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—AKT1—malignant glioma	6.07e-05	0.00207	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CAV1—malignant glioma	5.93e-05	0.00202	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—malignant glioma	5.86e-05	0.002	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FN1—malignant glioma	5.64e-05	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—F2—malignant glioma	5.64e-05	0.00192	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BAD—malignant glioma	5.57e-05	0.0019	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH1—malignant glioma	5.52e-05	0.00188	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—malignant glioma	5.41e-05	0.00184	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CD80—malignant glioma	5.41e-05	0.00184	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APC—malignant glioma	5.4e-05	0.00184	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CG—malignant glioma	5.4e-05	0.00184	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGF—malignant glioma	5.33e-05	0.00182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTPN11—malignant glioma	5.3e-05	0.00181	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BRAF—malignant glioma	5.07e-05	0.00173	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT2—malignant glioma	4.94e-05	0.00168	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—malignant glioma	4.92e-05	0.00167	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CD—malignant glioma	4.74e-05	0.00162	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—malignant glioma	4.7e-05	0.0016	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—RTEL1—malignant glioma	4.68e-05	0.00159	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KRAS—malignant glioma	4.65e-05	0.00158	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.63e-05	0.00158	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.56e-05	0.00155	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF2—malignant glioma	4.54e-05	0.00155	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—malignant glioma	4.27e-05	0.00145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MDM2—malignant glioma	4.25e-05	0.00145	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RAF1—malignant glioma	4.24e-05	0.00144	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB2—malignant glioma	4.19e-05	0.00143	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CB—malignant glioma	4.14e-05	0.00141	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—malignant glioma	3.97e-05	0.00135	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—malignant glioma	3.84e-05	0.00131	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—malignant glioma	3.8e-05	0.0013	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL2—malignant glioma	3.8e-05	0.00129	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—malignant glioma	3.59e-05	0.00122	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTEN—malignant glioma	3.57e-05	0.00122	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—malignant glioma	3.49e-05	0.00119	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—malignant glioma	3.23e-05	0.0011	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—malignant glioma	3.2e-05	0.00109	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—malignant glioma	2.97e-05	0.00101	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—malignant glioma	2.9e-05	0.000989	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KRAS—malignant glioma	2.74e-05	0.000935	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COX8A—malignant glioma	2.69e-05	0.000915	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—malignant glioma	2.52e-05	0.000859	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—malignant glioma	2.44e-05	0.000831	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ASMT—malignant glioma	2.28e-05	0.000778	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BCAN—malignant glioma	2.15e-05	0.000731	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—malignant glioma	2.06e-05	0.000702	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—IDH2—malignant glioma	1.73e-05	0.00059	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.63e-05	0.000554	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—IDH1—malignant glioma	1.49e-05	0.000507	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SPHK1—malignant glioma	1.44e-05	0.000491	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.41e-05	0.000481	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—malignant glioma	1.14e-05	0.000389	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS1—malignant glioma	1.07e-05	0.000364	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—BCHE—malignant glioma	9.94e-06	0.000339	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.82e-06	0.000335	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—malignant glioma	7.91e-06	0.000269	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—malignant glioma	7.7e-06	0.000262	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NCOR1—malignant glioma	7.27e-06	0.000248	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAV1—malignant glioma	5.93e-06	0.000202	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.4e-06	0.000184	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPARG—malignant glioma	5.21e-06	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.75e-06	0.000162	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.14e-06	0.000141	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—malignant glioma	4.1e-06	0.00014	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTEN—malignant glioma	3.57e-06	0.000122	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.52e-06	8.59e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—malignant glioma	2.06e-06	7.02e-05	CbGpPWpGaD
